Fábrica de peptídeos: capacitando a indústria com tecnologia, criando uma nova referência para a saúde com engenhosidade

Today, with the deep integration of the big health and biopharmaceutical industries, peptide factories have upgraded from traditional raw material manufacturers to core industrial forces that integrate technological innovation, green intelligent manufacturing, and full scenario services. With technology as the blade and craftsmanship as the foundation, modern peptide factories are redefining the production paradigm of functional peptides, making the health value of biological activity within reach.

Quality assurance is the foundation of peptide factories. Based on the pharmaceutical grade GMP workshop and cGMP international certification system, we have built a full chain quality control network from raw material traceability to finished product testing, equipped with cutting-edge equipment such as preparative HPLC and microwave-assisted synthesis instrument, to ensure that product purity remains stable at over 98% and impurity residues are far below industry standards. The raw material side selects deep-sea cod and plant substrates from gold producing areas, and innovatively uses beer yeast "micro factory" technology to synthesize highly active peptide molecules through biocatalysis, which combines biocompatibility and environmental safety, achieving a dual breakthrough of green production and efficient output.

Technological innovation drives industrial upgrading. The first fully automated and intelligent production line in China has achieved unmanned operation throughout the entire process, increasing production capacity by 30% while achieving a product qualification rate of 99.8%; By integrating continuous flow synthesis, 6T enzyme digestion, and AI assisted research and development technology, traditional production steps have been streamlined by 40%, solvent consumption has been significantly reduced, and efficient mass production of small molecule peptides with a molecular weight of ≤ 500Da has been achieved. It can be absorbed into the bloodstream in 10 minutes and has a bioavailability rate of over 95%. Build a super large peptide entity library, overcome the synthesis difficulties of large cyclic peptides and long peptides, provide billions of candidate molecules for pharmaceutical research and development, and shorten the development cycle of new drugs by half.

Empowering diverse needs with full scenario services. The intelligent production line with an annual production capacity of over 10000 tons can undertake orders for multiple dosage forms such as solid beverages and soft capsules, and deliver quickly within 32 days to meet the needs of brand branding and customized research and development. From intestinal care and anti-aging formulas in health products to precise treatment research and development in biomedicine, the peptide factory relies on nearly 200 patented technologies and the advantage of deep cooperation between industry, academia, and research. Its products are exported to more than 50 countries around the world, with a user repurchase rate of up to 80%. As the core carrier of "Chinese peptides" going global, peptide factories are using their hard core strength to promote high-quality industrial development and bring health technology to more people.